T. Rowe Price Associates’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
51,537
+6,388
| +14% | +$14K | ﹤0.01% | 2871 |
|
|
2025
Q1 | $124K | Buy |
45,149
+2,793
| +7% | +$7.67K | ﹤0.01% | 2777 |
|
|
2024
Q4 | $177K | Buy |
42,356
+8,951
| +27% | +$37.4K | ﹤0.01% | 2722 |
|
|
2024
Q3 | $130K | Hold |
33,405
| – | – | ﹤0.01% | 2768 |
|
|
2024
Q2 | $131K | Buy |
33,405
+8,206
| +33% | +$32.2K | ﹤0.01% | 2703 |
|
|
2024
Q1 | $106K | Buy |
25,199
+4,320
| +21% | +$18.2K | ﹤0.01% | 2770 |
|
|
2023
Q4 | $99K | Buy |
20,879
+2,082
| +11% | +$9.87K | ﹤0.01% | 2717 |
|
|
2023
Q3 | $59K | Buy |
18,797
+674
| +4% | +$2.12K | ﹤0.01% | 2751 |
|
|
2023
Q2 | $84K | Buy |
18,123
+1,494
| +9% | +$6.93K | ﹤0.01% | 2720 |
|
|
2023
Q1 | $83K | Buy |
16,629
+1,455
| +10% | +$7.26K | ﹤0.01% | 2716 |
|
|
2022
Q4 | $83K | Buy |
15,174
+1,681
| +12% | +$9.2K | ﹤0.01% | 2748 |
|
|
2022
Q3 | $88K | Buy |
+13,493
| New | +$88K | ﹤0.01% | 2750 |
|
|
2022
Q2 | – | Sell |
-37,018
| Closed | -$259K | – | 2990 |
|
|
2022
Q1 | $259K | Sell |
37,018
-519,798
| -93% | -$3.64M | ﹤0.01% | 2601 |
|
|
2021
Q4 | $5.67M | Buy |
556,816
+55,494
| +11% | +$565K | ﹤0.01% | 1480 |
|
|
2021
Q3 | $6.12M | Buy |
+501,322
| New | +$6.12M | ﹤0.01% | 1489 |
|